Nifty Ethosomes: Formulation and QbD-Based Optimization from Lab to Launch Transdermal Technology

Introduction: Ethosomes are flexible, lipid-based nanovesicles characterized by high ethanol content, enabling enhanced skin permeability and systemic drug delivery. Ethanol disrupts the lipid bilayer of the stratum corneum, facilitating deeper skin penetration and improved bioavailability of both hydrophilic and lipophilic drugs. Methods: Ethosomes are composed of a hydroethanolic core surrounded by an alipid bilayer, typically using soya lecithin, ethanol, and propylene glycol. They are generally prepared by the classic cold method. Design of Experiments (DoE), Response Surface Methodology (RSM), and Quality by Design (QbD) principles are utilized to optimize formulation parameters and under-stand factor interactions affecting ethosomal characteristics as described in the graphical abstract. Results: Particle sizes of Ethosomal formulations range between 78.99+16.72 nm and 321.53+10.41 nm, depending on ethanol and phospholipid concentrations. Valsartan-loaded ethosomes showed a particle size of 192.16 nm with an entrapment efficiency of 80.230 ± 0.8748%, and p<0.05. Curcumin-loaded ethosomes showed 81.2 ± 3.12 % entrapment efficiency, zeta potential -12 ± 3 to -29 ± 2, and 228.8 nm particle size. Flurbiprofen-loaded Ethosomes showed 95% EE%, − 48.14 ± 1.4mV zeta potential, 162.2 ± 2 nm particle size. Several drugs, including methoxsalen, indomethacin, Karanjin, metformin, Verdenafil Hydrochloride, and Thymoquinone, have been successfully encapsulated, demonstrating enhanced penetration, therapeutic efficacy, and controlled release profiles. Discussion: Optimization of formulation variables is essential to achieve high drug loading efficiency and nanometric particle size. The application of QbD and RSM enables robust, scalable Ethosomal systems suitable for both pharmaceutical and cosmeceutical applications. A notable example includes anti-cellulite creams under development, while commercial preparations such as Nanominox demonstrate real-world applicability. Conclusion: Ethosomes represent a promising, non-invasive nanocarrier system with versatile potential in drug delivery and cosmetic formulations. Their systematic development through QbD and DoE ensures consistent quality, scalability, and enhanced therapeutic outcomes.